Quarterly report pursuant to sections 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v2.4.0.8
Condensed Statements of Operations (Unaudited) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Revenues:        
Related party license revenues   $ 650,000 $ 650,000 $ 1,300,000
Service revenues 65,116 142,404 219,062 250,734
Product revenues 497,373 291,356 957,626 513,025
Total revenues 562,489 1,083,760 1,826,688 2,063,759
Costs and operating expenses:        
Cost of product revenues 295,777 156,757 522,108 258,426
Research and development costs 741,817 486,022 1,513,270 1,175,691
Reversal of R&D obligation   (882,537)   (882,537)
Selling, general, and administrative 1,703,191 1,803,045 3,336,638 3,143,148
Total costs and operating expenses 2,740,785 1,563,287 5,372,016 3,694,728
Operating loss (2,178,296) (479,527) (3,545,328) (1,630,969)
Other income (expense):        
Gain on change in fair value of deriviative liabilities 955,271   2,578,969 (26,545)
Loss on note payable modification     (1,356,177)  
Other income (expense), net (6,945) (25,795) 367,388 (24,625)
Interest income 7,771 1,361 14,890 2,980
Interest expense (129,733) (96,018) (235,422) (2,421,754)
Net loss $ (1,351,932) $ (599,979) $ (2,175,680) $ (4,074,368)
Net loss per share attributable to common stockholders:        
Basic and diluted (in Dollars per share) $ (0.02) $ (0.01) $ (0.04) $ (0.12)
Weighted average shares outstanding:        
Basic and diluted (in Shares) 57,384,247 40,596,069 56,129,908 32,891,808